PharmaShots | Incisive News in 3 Shots

Subscribe Now

Reducing

Nestle Health Science Signs a Worldwide Exclusive Agreement with VALBIOTIS to Develop and Commercialize TOTUM-63 for Reducing the Risk of T2D

Nestle Health Science Signs a Worldwide Exclusive Agreement with VALBIOTIS to Develop and Commercialize TOTUM-63 for Reducing the...

February 6, 2020

Novartis' Adakveo (crizanlizumab) Receives the US FDA's Approval for Reducing the Frequency of VOCs in Sickle Cell Disease

Novartis' Adakveo (crizanlizumab) Receives the US FDA's Approval for Reducing the Frequency of VOCs in Sickle Cell Disease

November 18, 2019

AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Approval for Reducing the Risk of Hospitalization for Heart Failure in Patients with Type-2 Diabetes

AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Approval for Reducing the Risk of Hospitalization for Heart Failure in...

October 21, 2019

Medtronic Reports Results of MiniMed 640G System in the SMILE Study for Reducing Hypoglycemia in Patients with Type 1 Diabetes

Medtronic Reports Results of MiniMed 640G System in the SMILE Study for Reducing Hypoglycemia in Patients with Type 1 Diabetes

May 9, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us